Virax Biolabs Group Limit...

1.09
0.07 (6.86%)
At close: Apr 24, 2025, 3:57 PM
1.10
0.84%
Pre-market: Apr 25, 2025, 08:00 AM EDT

Virax Biolabs Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021 Q4 2020
Period Ending Sep 30, 2024 Mar 31, 2024 Sep 30, 2023 Mar 31, 2023 Sep 30, 2022 Mar 31, 2022 Sep 30, 2021 Mar 31, 2021 Sep 30, 2020 Mar 31, 2020
-2.76M -3.82M -2.91M -4.01M -1.44M -1.16M -552.42K -307.53K -343.46K -184.87K
158.19K 85.38K 17.72K n/a n/a n/a n/a n/a n/a n/a
38.98K 925.7K 86.27K 1.51M 248.98K 290.36K 287.44K n/a n/a n/a
333.63K 675.58K -328.69K 485.33K -722.56K 12.46K -10.28K 2.00 0.00 n/a
374.24K -58.79K 312.65K 865.12K 607.93K -650.26K 263.43K -35.63K -22.79K 22.92K
n/a n/a -378.84K n/a n/a n/a n/a n/a n/a n/a
266.39K 82.23K -585.82K 875.42K -1.09M 644.38K 12.00 86.22K -26.6K -24.2K
-1.92M -2.79M -3.46M -1.88M -2.3M -530.38K -278.68K -170.73K -419.46K -186.15K
-248K -459.92K -708.18K -178.4K n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 3.65K -215.6K -178.4K n/a n/a n/a n/a n/a n/a
-248K -456.27K -708.18K -178.4K n/a -24.66K n/a n/a n/a -245.25
-51.55K -3.66K -146.25K 146.25K n/a n/a n/a n/a n/a n/a
n/a -85.5K n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
5.91M 1.82M 67.44K -398.95K 6.84M 120.85K 272.74K 123.23K 461.97K 176.16K
5.86M 1.73M -78.81K 6.84M 6.84M 540.47K 272.74K 123.23K 461.97K 176.16K
7.29M -1.52M -4.24M 4.78M 4.55M 10.08K -5.95K -47.5K 42.51K -9.99K
-2.17M -3.25M -4.17M -2.06M -2.3M -530.38K -278.68K -170.73K -419.46K -186.15K